Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship.

NCT07013435 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07013435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07013435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship.
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 6, 2026
Completion date
August 31, 2030
Enrollment
254 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma